![]() | |
![]() | |
Combination of | |
---|---|
Estradiol benzoate butyrate | Estrogen |
Algestone acetophenide | Progestogen |
Clinical data | |
Trade names | Neolutin N, Redimen, Soluna, Unijab |
Other names | Estradiol benzoate butyrate/dihydroxyprogesterone acetophenide; EBB/DHPA; Unimens |
Routes of administration | Intramuscular injection |
Estradiol benzoate butyrate/algestone acetophenide, also known as estradiol benzoate butyrate/dihydroxyprogesterone acetophenide (EBB/DHPA) and sold under the brand names Neolutin N, Redimen, Soluna, and Unijab, is a form of combined injectable birth control which is used in Peru and Singapore. [1] [2] [3] [4] [5] [6] It contains estradiol benzoate butyrate (EBB), an estrogen, and algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA), a progestin. [2] [3] The medication is given once per month by injection into muscle. [3]
EBB/DHPA is used as a once-a-month combined injectable contraceptive to prevent pregnancy in women. [1] [2] [3]
EBB/DHPA contains 10 mg estradiol benzoate butyrate (EBB), an estrogen, and 150 mg algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA), a progestin. [2] [3]
EBB/DHPA has been said to have relatively weak estrogenic activity and has been described as "progestogen-dominant". [1]
EBB is said to have a shorter duration than estradiol enantate of about 3 weeks. [7] EBB/DHPA was developed because it was thought that the duration of EBB would be more suitable for use as a once-monthly combined injectable contraceptive than estradiol enantate in estradiol enantate/algestone acetophenide. [7]
EBB/DHPA is marketed under the brand names Neolutin N, Redimen, Soluna, and Unijab. [1] [2] [3] [4] [5] [6] [8] It was originally developed under the tentative brand name Unimens, but ultimately was not marketed under this particular brand name. [1] [7] [9] [10] [11]
EBB/DHPA is available only in Peru and Singapore. [2] [3]
{{
cite web}}
: CS1 maint: archived copy as title (
link)
![]() | |
![]() | |
Combination of | |
---|---|
Estradiol benzoate butyrate | Estrogen |
Algestone acetophenide | Progestogen |
Clinical data | |
Trade names | Neolutin N, Redimen, Soluna, Unijab |
Other names | Estradiol benzoate butyrate/dihydroxyprogesterone acetophenide; EBB/DHPA; Unimens |
Routes of administration | Intramuscular injection |
Estradiol benzoate butyrate/algestone acetophenide, also known as estradiol benzoate butyrate/dihydroxyprogesterone acetophenide (EBB/DHPA) and sold under the brand names Neolutin N, Redimen, Soluna, and Unijab, is a form of combined injectable birth control which is used in Peru and Singapore. [1] [2] [3] [4] [5] [6] It contains estradiol benzoate butyrate (EBB), an estrogen, and algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA), a progestin. [2] [3] The medication is given once per month by injection into muscle. [3]
EBB/DHPA is used as a once-a-month combined injectable contraceptive to prevent pregnancy in women. [1] [2] [3]
EBB/DHPA contains 10 mg estradiol benzoate butyrate (EBB), an estrogen, and 150 mg algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA), a progestin. [2] [3]
EBB/DHPA has been said to have relatively weak estrogenic activity and has been described as "progestogen-dominant". [1]
EBB is said to have a shorter duration than estradiol enantate of about 3 weeks. [7] EBB/DHPA was developed because it was thought that the duration of EBB would be more suitable for use as a once-monthly combined injectable contraceptive than estradiol enantate in estradiol enantate/algestone acetophenide. [7]
EBB/DHPA is marketed under the brand names Neolutin N, Redimen, Soluna, and Unijab. [1] [2] [3] [4] [5] [6] [8] It was originally developed under the tentative brand name Unimens, but ultimately was not marketed under this particular brand name. [1] [7] [9] [10] [11]
EBB/DHPA is available only in Peru and Singapore. [2] [3]
{{
cite web}}
: CS1 maint: archived copy as title (
link)